Table 1.

Patient and disease characteristics according to FLT3 mutational status

^*, FLT3 internal tandem duplication (ITD) or D835 point mutation of tyrosine kinase domain (TKD) was identified in this group; ^†, mixed means biphenotypic or bilineage leukemia.

RAEB-t, refractory anemia with excess blast in transformation; CBC, complete blood count; LDH, latacte dehydrogenase.